Free access to the McMaster Textbook app and website We are thrilled to announce free access to the McMaster Textbook app and website for users in Canada and the United States. Click to read more.
Curative therapy for red cell disorders: A whirlwind tour Dr Sarah Patterson from McMaster University provides a review of therapies for sickle cell disease and thalassemia.
Publications of the Week: Dual antiplatelet therapy following ischemic stroke A digest of noteworthy publications from McMaster experts. This week’s focus: DAPT started within 72 hours after the onset of stroke.
Publications of the Week: Skin antisepsis before fracture-management surgeries A digest of noteworthy publications from McMaster experts. This week’s focus: preventing infections before orthopedic surgeries: chlorhexidine or iodine?
Cardiac PET and its utility in cardiac risk stratification Dr Vikas Tandon from McMaster University discusses the basics of nuclear myocardial perfusion imaging (MPI) as well as clinical indications for MPI.
Publications of the Week: Colchicine following myocardial infarction: The effects among patients with diabetes A digest of noteworthy publications from McMaster experts. This week’s focus: colchicine following MI in patients with type 2 diabetes.
Improving the care of people who use drugs in hospital Dr Tim O'Shea and Dr Robin Lennox from McMaster University discuss challenges in the care of people using drugs in the hospital environment.
Are glucocorticoids still the mainstay of treatment in polymyalgia rheumatica and giant cell arteritis? Are glucocorticoids still the mainstay of treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), or should we consider glucocorticoid-sparing agents earlier than before?
Thromboprophylaxis in individuals with obesity in the ICU How to prevent thrombosis in a patient with obesity in the intensive care unit?
Publications of the Week: Long COVID and gut microbiome modification: Too good to be true? A digest of noteworthy publications from McMaster experts. This week’s focus: long COVID and gut microbiome modification.